ATE368476T1 - Neuropeptid-y1-rezeptor-bindende verbindungen zur behandlung und diagnose von krebserkrankungen - Google Patents

Neuropeptid-y1-rezeptor-bindende verbindungen zur behandlung und diagnose von krebserkrankungen

Info

Publication number
ATE368476T1
ATE368476T1 AT00204183T AT00204183T ATE368476T1 AT E368476 T1 ATE368476 T1 AT E368476T1 AT 00204183 T AT00204183 T AT 00204183T AT 00204183 T AT00204183 T AT 00204183T AT E368476 T1 ATE368476 T1 AT E368476T1
Authority
AT
Austria
Prior art keywords
neuropeptide
diagnosis
treatment
receptor binding
binding compounds
Prior art date
Application number
AT00204183T
Other languages
English (en)
Inventor
Jean-Claude Reubi
Original Assignee
Jean-Claude Reubi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean-Claude Reubi filed Critical Jean-Claude Reubi
Application granted granted Critical
Publication of ATE368476T1 publication Critical patent/ATE368476T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00204183T 2000-11-24 2000-11-24 Neuropeptid-y1-rezeptor-bindende verbindungen zur behandlung und diagnose von krebserkrankungen ATE368476T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00204183A EP1208852B1 (de) 2000-11-24 2000-11-24 Neuropeptid-Y1-Rezeptor-bindende Verbindungen zur Behandlung und Diagnose von Krebserkrankungen

Publications (1)

Publication Number Publication Date
ATE368476T1 true ATE368476T1 (de) 2007-08-15

Family

ID=8172328

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00204183T ATE368476T1 (de) 2000-11-24 2000-11-24 Neuropeptid-y1-rezeptor-bindende verbindungen zur behandlung und diagnose von krebserkrankungen

Country Status (7)

Country Link
US (1) US20040076581A1 (de)
EP (1) EP1208852B1 (de)
AT (1) ATE368476T1 (de)
AU (1) AU2002220723A1 (de)
CA (1) CA2429632A1 (de)
DE (1) DE60035787T2 (de)
WO (1) WO2002043776A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040106548A1 (en) * 2001-09-07 2004-06-03 Schmidt Michelle A Conformationally constrained labeled peptides for imaging and therapy
WO2007039318A2 (en) * 2005-10-06 2007-04-12 Bayer Schering Pharma Aktiengesellschaft Neuropeptide y analogs
BRPI1008882A2 (pt) 2009-02-20 2016-03-15 Ipsen Pharma Sas composto, composição farmacêutica, e uso de um composto ou composição farmacêutica
CN102325540B (zh) * 2009-02-20 2015-09-23 益普生制药股份有限公司 具有至少一个合成的氨基酸替换的神经肽y的类似物
JP5584236B2 (ja) * 2009-02-20 2014-09-03 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ 神経ペプチドｙ受容体結合化合物を有する細胞毒性コンジュゲート

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0599303A3 (de) * 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Peptide-Konjugate
US6114390A (en) * 1995-11-30 2000-09-05 Karl Thomae Gmbh Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
EP0892053A3 (de) * 1997-07-14 1999-12-29 Smithkline Beecham Plc Herstellung von rekombinantem HPMBQ91 Polypeptide und dessen Verwendungen
CA2360419C (en) * 1999-02-24 2009-09-22 Mallinckrodt, Inc. Molecules for the treatment and diagnosis of tumours
AU6718900A (en) * 1999-07-05 2001-01-22 Pedro Ortiz Armua A radiolabeled mammalian tachykinin peptide analogue

Also Published As

Publication number Publication date
US20040076581A1 (en) 2004-04-22
AU2002220723A1 (en) 2002-06-11
CA2429632A1 (en) 2002-06-06
WO2002043776A3 (en) 2002-10-10
EP1208852A1 (de) 2002-05-29
EP1208852B1 (de) 2007-08-01
DE60035787D1 (de) 2007-09-13
DE60035787T2 (de) 2008-04-30
WO2002043776A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
DE60028970D1 (de) An her2 bindende peptidverbindungen
GEP20084484B (en) Antibodies to insulin-like growth factor i receptor
UA90457C2 (ru) Человеческое моноклональное антитело, которое специфически связывается с м-csf человека и блокирует связывание м-csf с с-fms
DE60011612D1 (de) Zusammensetzungen und Verfahren zur Krebsbehandlung durch die selektive Hemmung von VEGF
DE60231341D1 (de) Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
DE60143857D1 (de) Zusammensetzung bestehend aus phy906 und chemotherapeutika
ATE409181T1 (de) Proteomimetische verbindungen und verfahren
TW200510429A (en) Heterocyclic MCHR1 antagonists
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
EP1363629A4 (de) Kappa-opioid-rezeptor-liganden
MY137552A (en) Methods for treating rheumatic diseases using a soluble ctla4 molecule
CY1106662T1 (el) Αντι-igf-ir αντισωματα και οι εφαρμογες τους
MX2009003093A (es) Composiciones y metodos relacionados con anticuerpos del receptor de glucagon.
SE9702483D0 (sv) New compound
IS7965A (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
MXPA04003858A (es) Antagonistas de mch para el tratamiento de obesidad.
ZA200508389B (en) Humanized antibodies to interferon alpha receptor-1(IFNAR-1)
ATE439833T1 (de) Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten
DE60129518D1 (de) Verwendung von einem Vasopressin-Antagonisten wie Conivaptan zur Herstellung eines Medikaments für die Behandlung der pulmonalen Hypertension
DE60213629D1 (de) Piperidinverbindungen als muscarinantagonisten
ATE368476T1 (de) Neuropeptid-y1-rezeptor-bindende verbindungen zur behandlung und diagnose von krebserkrankungen
ATE402958T1 (de) Antagonisten des ige-rezeptors
TR200103638T2 (tr) IL-8 Reseptör antagonistleri
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties